Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Shareholders approve Kimberly-Clark’s $48B purchase of Tylenol maker

Summary by The Business Journals
The multibillion-dollar deal, slated to close in the second half of the year, will create a combined organization that will generate estimated annual revenue of about $32 billion. Read on to learn the latest about Kimerbly-Clark's big buy.

1 Articles

The Business JournalsThe Business Journals
Center

Shareholders approve Kimberly-Clark’s $48B purchase of Tylenol maker

The multibillion-dollar deal, slated to close in the second half of the year, will create a combined organization that will generate estimated annual revenue of about $32 billion. Read on to learn the latest about Kimerbly-Clark's big buy.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Business Journals broke the news in United States on Monday, February 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tylenol icon

Tylenol

Dallas, Texas icon

Dallas, Texas

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal